DOI: https://doi.org/10.22141/2224-0586.2.57.2014.83107

Risk of Insomnia Pharmacotherapy and Preventive Measures to Manage it

S.M. Drogovoz, V.D. Lukyanchuk, B.S. Sheyman, E.L. Тоryanik

Abstract


Insomnia — a fairly common disease requiring mandatory treatment. Despite the fact that there are over-the-counter sleeping pills, overdose with them causes dangerous complications, which requires knowledge of the last, as well as the conditions and factors that contribute to an overdose of hypnotics and reduce it. If in subjective dissatisfaction of sleep its objectively registered duration is longer than 6 hours, and its structure is normal, the administration of sleeping pills is inappropriate.


Keywords


insomnia; hypnotics; toxicity

References


Инсомния: современные диагностические и лечебные подходы / Под ред. проф. Я.И. Левина. — М.: Медпрактика, 2005. — 115 с.

Ковров Г.В. Стресс и сон у человека / Г.В. Ковров, А.М. Вейн. — М.: Нейромедиа, 2004. — 96 с.

Котова О.В. Современные аспекты терапии инсомнии / О.В. Котова, И.В. Рябоконь // Лечащий врач. — 2013. — № 5. — http://www.lvrach.ru/2013/05/15435695/

Левин Я.И. Некоторые современные подходы к терапии инсомнии / Я.И. Левина, Г.В. Ковров // Лечащий врач. — 2003. — № 4. — C. 18-24.

Побочное действие лекарств: Учебник-справочник / Дроговоз С.М., Гудзенко А.П., Бутко Я.А., Дроговоз В.В. — Х., 2010. — 480 с.

Фармакология в помощь студенту, провизору и врачу: Учебник-справочник / Дроговоз С.М., Штрыголь С.Ю., Щекина Е.Г. — Х.: Титул, 2013. — 900 с.

Аведисова А.С. Гипнотики: от фенобарбитала к ивадалу // Русский медицинский журнал. — 2002. — Т. 10, № 2. — C. 60-65.

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison / G.D. Jacobs, E.F. Pace-Schott, R. Stickgold, M.W. Otto // Arch. Intern. Med. — 2004. — № 164. — P. 1888-1896.

Long-term, non-nightly administration of Zolpidem in the treatment of patients with primary insomnia / M.L. Perlis, W.V. McCall, A.D. Krystal, J.K. Walsh // J. Clin. Psychiatry. — 2004. — № 65. — P. 1128-1137.

Potential action of melatonin in insomnia / N.L. Rogers, D.F. Dinges, D.J. Kennaway, D. Dawson // Sleep. — 2003. — № 26. — P. 1058-1059.

Practice parameters for using polysomnography to evaluate insomnia: an update / M. Littner, M. Hirshkowitz, M. Kramer et al. // Sleep. — 2003. — № 26. — P. 754-60.

Sustained efficacy of eszopiclone over 6 months of nighdy treatment: results of a randomized, double-blind, placebo-controlled study of adults with chronic insomnia / A.D. Krystal, J.K. Walsh, E. Laska et al. // Sleep. — 2003. — № 26. –P. 793-799.

The effects of trazodone on sleep in patients treated with stimulant antidepressants / H. Kaynak, D. Kaynak, E. Gozukirmizi, C. Guilleminault // Sleep Med. — 2004. — № 5. — P. 15-20.

The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial / F.P. Zemlan, J.J. Mulchahey, M.B. Scharf et al. // J. Clin. Psychiatry. — 2005. — № 66. — P. 384-390.

The international classification of sleep disorders: diagnostic & coding manual, ICDS-2. — 2nd ed. — Westchester, 111: American Academy of Sleep Medicine, 2005. — 401 p.




Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта